Sign in
A randomised double-blind trial of liraglutide to control HbA(1c) in subjects with type 2 diabetes treated with multiple daily insulin injections (MDILiraglutide trial)
Conference proceeding   Peer reviewed

A randomised double-blind trial of liraglutide to control HbA(1c) in subjects with type 2 diabetes treated with multiple daily insulin injections (MDILiraglutide trial)

M Lind, I Hirsch, J Tuomilehto, S Dahlqvist, B Ahren, O Torffvit, S Attvall, M Ekelund, K Filipsson, B O Tengmark, …
DIABETOLOGIA, Vol.58, p.S37
2015

Abstract

Medicin och hälsovetenskap

Metrics

1 Record Views

Details